Kentucky Retirement Systems trimmed its position in The Clorox Company (NYSE:CLX – Free Report) by 1.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,512 shares of the company’s stock after selling 117 shares during the quarter. Kentucky Retirement Systems’ holdings in Clorox were worth $1,382,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. State Street Corp grew its position in Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after acquiring an additional 245,525 shares during the period. Mizuho Securities USA LLC lifted its stake in Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after buying an additional 4,490,421 shares during the period. Geode Capital Management LLC raised its position in shares of Clorox by 1.1% during the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after purchasing an additional 33,970 shares during the period. Stifel Financial Corp raised its position in shares of Clorox by 1.7% during the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after purchasing an additional 37,967 shares during the period. Finally, Van ECK Associates Corp raised its position in shares of Clorox by 2.2% during the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after purchasing an additional 31,510 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Clorox Trading Up 2.8 %
NYSE CLX opened at $157.41 on Monday. The firm has a market capitalization of $19.39 billion, a PE ratio of 43.01, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The business’s 50-day moving average price is $157.72 and its two-hundred day moving average price is $159.96. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on CLX shares. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and raised their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Evercore ISI raised their price target on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Barclays lifted their target price on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. DA Davidson dropped their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Finally, StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $158.21.
View Our Latest Stock Report on CLX
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- Financial Services Stocks Investing
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- How to buy stock: A step-by-step guide for beginners
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- What Are Treasury Bonds?
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.